Logo image of KOVO.CA

KOVO+ HOLDINGS INC (KOVO.CA) Stock Fundamental Analysis

TSX-V:KOVO - TSX Venture Exchange - CA5007421012 - Common Stock - Currency: CAD

0.04  -0.01 (-20%)

Fundamental Rating

0

Taking everything into account, KOVO scores 0 out of 10 in our fundamental rating. KOVO was compared to 6 industry peers in the Health Care Technology industry. Both the profitability and financial health of KOVO have multiple concerns. KOVO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

KOVO had negative earnings in the past year.
KOVO had a negative operating cash flow in the past year.
KOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFKOVO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -1M -2M -3M -4M

1.2 Ratios

Looking at the Return On Assets, with a value of -50.23%, KOVO is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
ROA -50.23%
ROE N/A
ROIC N/A
ROA(3y)-30.34%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
KOVO.CA Yearly ROA, ROE, ROICKOVO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

KOVO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KOVO.CA Yearly Profit, Operating, Gross MarginsKOVO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 -10 -20 -30 -40

More info and screens

1

2. Health

2.1 Basic Checks

KOVO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, KOVO has more shares outstanding
Compared to 1 year ago, KOVO has an improved debt to assets ratio.
KOVO.CA Yearly Shares OutstandingKOVO.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 10M 20M 30M 40M 50M
KOVO.CA Yearly Total Debt VS Total AssetsKOVO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2M 4M 6M 8M

2.2 Solvency

Based on the Altman-Z score of -2.65, we must say that KOVO is in the distress zone and has some risk of bankruptcy.
KOVO has a better Altman-Z score (-2.65) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.65
ROIC/WACCN/A
WACC10.26%
KOVO.CA Yearly LT Debt VS Equity VS FCFKOVO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 1M -1M 2M 3M 4M

2.3 Liquidity

KOVO has a Current Ratio of 0.08. This is a bad value and indicates that KOVO is not financially healthy enough and could expect problems in meeting its short term obligations.
KOVO's Current ratio of 0.08 is on the low side compared to the rest of the industry. KOVO is outperformed by 71.43% of its industry peers.
A Quick Ratio of 0.08 indicates that KOVO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.08, KOVO is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
KOVO.CA Yearly Current Assets VS Current LiabilitesKOVO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for KOVO have decreased strongly by -1300.00% in the last year.
KOVO shows a decrease in Revenue. In the last year, the revenue decreased by -5.04%.
EPS 1Y (TTM)-1300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.72%
Revenue 1Y (TTM)-5.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KOVO.CA Yearly Revenue VS EstimatesKOVO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2M 4M 6M 8M 10M
KOVO.CA Yearly EPS VS EstimatesKOVO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

KOVO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KOVO.CA Price Earnings VS Forward Price EarningsKOVO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KOVO.CA Per share dataKOVO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

KOVO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KOVO+ HOLDINGS INC

TSX-V:KOVO (3/7/2025, 7:00:00 PM)

0.04

-0.01 (-20%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-29 2024-08-29
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners79.06%
Ins Owner ChangeN/A
Market Cap7.08M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.08
BVpS-0.02
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -50.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.34%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.54%
Cap/Sales 2.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -2.65
F-Score2
WACC10.26%
ROIC/WACCN/A
Cap/Depr(3y)45.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.45%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-12.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-462.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.71%
OCF growth 3YN/A
OCF growth 5YN/A